This study is led by Dr. Amy Hsu from the Bruyère Research Institute and Professor

Marc-André Langlois at the University of Ottawa, and involves many researchers from universities across Canada.


The goals of this study are to build a better understanding about how widespread

COVID-19 is in our most vulnerable and

high-risk populations, and to study the level and duration of protection of currently approved COVID-19 vaccines.


Research Progress

Want to know what we are working on? Find out here!


About The Team

Meet the multi-disciplinary team

of scientists and research staff behind this study.

In collaboration with